Literature DB >> 8757834

Induction of cytokine granulocyte-macrophage colony-stimulating factor and chemokine macrophage inflammatory protein 2 mRNAs in macrophages by Legionella pneumophila or Salmonella typhimurium attachment requires different ligand-receptor systems.

Y Yamamoto1, T W Klein, H Friedman.   

Abstract

The attachment of bacteria to macrophages is mediated by different ligands and receptors and induces various intracellular molecular responses. In the present study, induction of cytokines and chemokines, especially granulocyte-macrophage colony-stimulating factor (GM-CSF) and macrophage inflammatory protein 2 (MIP-2), was examined, following bacterial attachment, with regard to the ligand-receptor systems involved. Attachment of Legionella pneumophila or Salmonella typhimurium to cultured mouse peritoneal macrophages increased the steady-state levels of cellular mRNAs for the cytokines interleukin 1beta (IL-1beta), IL-6, and GM-CSF as well as the chemokines MIP-1beta, MIP-2, and KC. However, when macrophages were treated with alpha-methyl-D-mannoside (alphaMM), a competitor of glycopeptide ligands, induction of cytokine mRNAs was inhibited, but the levels of chemokine mRNAs were not. Pretreatment of the bacteria with fresh mouse serum enhanced the level of GM-CSF mRNA but not the level of MIP-2 mRNA. In addition, serum treatment reduced the inhibitory effect of alphaMM on GM-CSF mRNA. These results indicate that bacterial attachment increases the steady-state levels of the cytokine and chemokine mRNAs tested by at least two distinct receptor-ligand systems, namely, one linked to cytokine induction and involving mannose or other sugar residues and the other linked to chemokine induction and relatively alphaMM insensitive. Furthermore, opsonization with serum engages other pathways in the cytokine response which are relatively independent of the alphaMM-sensitive system. Regarding bacterial surface ligands involved in cytokine mRNA induction, evidence is presented that the flagellum may be important in stimulating cytokine GM-CSF message but not chemokine MIP-2 message. Analysis of cytokine GM-CSF and chemokine MIP-2 signaling pathways with protein kinase inhibitors revealed the involvement of calmodulin and myosin light-chain kinase in GM-CSF but not MIP-2 mRNA induction, adding further evidence that several distinct receptor systems are engaged during the process of bacterial attachment and induction of cytokines and chemokines, such as GM-CSF and MIP-2, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757834      PMCID: PMC174188          DOI: 10.1128/iai.64.8.3062-3068.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

Review 1.  Biology of the RANTES/SIS cytokine family.

Authors:  T J Schall
Journal:  Cytokine       Date:  1991-05       Impact factor: 3.861

2.  Ca2+ and calmodulin selectively regulate lipopolysaccharide-inducible cytokine mRNA expression in murine peritoneal macrophages.

Authors:  Y Ohmori; T A Hamilton
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

3.  Induction of interleukin 1 by Legionella pneumophila antigens in mouse macrophage and human mononuclear leukocyte cultures.

Authors:  T W Klein; C A Newton; D K Blanchard; R Widen; H Friedman
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1987-07

4.  Differential inhibition of T cell receptor signal transduction and early activation events by a selective inhibitor of protein-tyrosine kinase.

Authors:  J M Trevillyan; Y L Lu; D Atluru; C A Phillips; J M Bjorndahl
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

5.  Bacteroides (Porphyromonas) gingivalis fimbriae activate mouse peritoneal macrophages and induce gene expression and production of interleukin-1.

Authors:  S Hanazawa; Y Murakami; K Hirose; S Amano; Y Ohmori; H Higuchi; S Kitano
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

6.  Method for the isolation of highly purified Salmonella flagellins.

Authors:  G F Ibrahim; G H Fleet; M J Lyons; R A Walker
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

7.  Roles of motility and flagellar structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in three animal models.

Authors:  K Richardson
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

8.  Virulence of non-type 1-fimbriated and nonfimbriated nonflagellated Salmonella typhimurium mutants in murine typhoid fever.

Authors:  H A Lockman; R Curtiss
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

Review 9.  Properties of the novel proinflammatory supergene "intercrine" cytokine family.

Authors:  J J Oppenheim; C O Zachariae; N Mukaida; K Matsushima
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

10.  Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors.

Authors:  N R Payne; M A Horwitz
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  10 in total

1.  Salmonella typhi flagella are potent inducers of proinflammatory cytokine secretion by human monocytes.

Authors:  T L Wyant; M K Tanner; M B Sztein
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

2.  Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila.

Authors:  Toshiaki Kikuchi; Sita Andarini; Hong Xin; Kazunori Gomi; Yutaka Tokue; Yasuo Saijo; Tasuku Honjo; Akira Watanabe; Toshihiro Nukiwa
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Host microarray analysis reveals a role for the Salmonella response regulator phoP in human macrophage cell death.

Authors:  C S Detweiler; D B Cunanan; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

4.  Differential effects of virulent versus avirulent Legionella pneumophila on chemokine gene expression in murine alveolar macrophages determined by cDNA expression array technique.

Authors:  N Nakachi; K Matsunaga; T W Klein; H Friedman; Y Yamamoto
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Involvement of mannose receptor in cytokine interleukin-1beta (IL-1beta), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1beta (MIP-1beta), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages.

Authors:  Y Yamamoto; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 6.  Bacterial perturbation of cytokine networks.

Authors:  M Wilson; R Seymour; B Henderson
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

7.  Virulent Francisella tularensis destabilize host mRNA to rapidly suppress inflammation.

Authors:  Timothy J Bauler; Jennifer C Chase; Tara D Wehrly; Catharine M Bosio
Journal:  J Innate Immun       Date:  2014-05-27       Impact factor: 7.349

8.  Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar Typhimurium infection.

Authors:  Freddy A Medina; Cecilia J de Almeida; Elliott Dew; Jiangwei Li; Gloria Bonuccelli; Terence M Williams; Alex W Cohen; Richard G Pestell; Philippe G Frank; Herbert B Tanowitz; Michael P Lisanti
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

9.  A cytosolic serine endopeptidase from Trypanosoma cruzi is required for the generation of Ca2+ signaling in mammalian cells.

Authors:  B A Burleigh; E V Caler; P Webster; N W Andrews
Journal:  J Cell Biol       Date:  1997-02-10       Impact factor: 10.539

10.  Consequences of Vitamin A Deficiency: Immunoglobulin Dysregulation, Squamous Cell Metaplasia, Infectious Disease, and Death.

Authors:  Sherri L Surman; Rhiannon R Penkert; Robert E Sealy; Bart G Jones; Tony N Marion; Peter Vogel; Julia L Hurwitz
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.